Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Behnam Ahmadian Baghbaderani"'
Autor:
Sahana Suresh Babu, Haritha Duvvuru, Jillian Baker, Stephanie Switalski, Mehdi Shafa, Krishna Morgan Panchalingam, Saedeh Dadgar, Justin Beller, Behnam Ahmadian Baghbaderani
Publikováno v:
Biotechnology Reports, Vol 37, Iss , Pp e00784- (2023)
Human induced pluripotent stem cells (iPSC) have demonstrated massive potentials for use in regenerative and personalized medicine due to their ability to expand in culture and differentiate into specialized cells with therapeutic benefits. However,
Externí odkaz:
https://doaj.org/article/235e6f3b53554a05ae76361a1d5fb6b7
Autor:
Mehdi Shafa, Tylor Walsh, Krishna Morgan Panchalingam, Thomas Richardson, Laura Menendez, Xinghui Tian, Sahana Suresh Babu, Saedeh Dadgar, Justin Beller, Fan Yang, Behnam Ahmadian Baghbaderani
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 1, p 108 (2019)
The clinical effectiveness of human induced pluripotent stem cells (iPSCs) is highly dependent on a few key quality characteristics including the generation of high quality cell bank, long-term genomic stability, post-thaw viability, plating efficien
Externí odkaz:
https://doaj.org/article/5b360ceca49d4c00b6539532a0b7b5d3
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
The discovery of reprogramming and generation of human-induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine and opened new opportunities in cell replacement therapies. While generation of iPSCs represents a sig
Externí odkaz:
https://doaj.org/article/b56ce5d58211405eb37a3072d5bd1b10
Autor:
Behnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo, Amy Burkall, Tracy Dimezzo, Guadalupe Sierra, Xianmin Zeng, Kim Warren, Don Paul Kovarcik, Thomas Fellner, Mahendra S. Rao
Publikováno v:
Stem Cell Reports, Vol 5, Iss 4, Pp 647-659 (2015)
The discovery of induced pluripotent stem cells (iPSCs) and the concurrent development of protocols for their cell-type-specific differentiation have revolutionized our approach to cell therapy. It has now become critical to address the challenges re
Externí odkaz:
https://doaj.org/article/87a6c61b95c549c695317ba1ea0d7b9d
Autor:
Behnam Ahmadian Baghbaderani, Xinghui Tian, Jean Scotty Cadet, Kevan Shah, Amy Walde, Huan Tran, Don Paul Kovarcik, Diana Clarke, Thomas Fellner
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161229 (2016)
Human pluripotent stem cells (hPSCs) present an unprecedented opportunity to advance human health by offering an alternative and renewable cell resource for cellular therapeutics and regenerative medicine. The present demand for high quality hPSCs fo
Externí odkaz:
https://doaj.org/article/ce0be25514bb4f53a57f3c137d96d565
Autor:
Behnam Ahmadian Baghbaderani
Publikováno v:
Cell and Gene Therapy Insights. :1329-1338
Autor:
Dadgar Saedeh, Kuruvilla Vinitha Mary, Duvvuru Haritha, Babu Sahana Suresh, Beller Justin, Behnam Ahmadian Baghbaderani
Publikováno v:
International Journal of Stem Cell Research & Therapy. 9
Publikováno v:
The Canadian Journal of Chemical Engineering. 99:2505-2516
Autor:
Behnam Ahmadian Baghbaderani
Publikováno v:
Cell and Gene Therapy Insights. 6:469-479
Autor:
Tylor Walsh, Thomas Richardson, Behnam Ahmadian Baghbaderani, Mehdi Shafa, Krishna M. Panchalingam
Publikováno v:
Biotechnology and Bioengineering
Induced pluripotent stem cells (iPSCs) hold great potential to generate novel, curative cell therapy products. However, current methods to generate these novel therapies lack scalability, are labor‐intensive, require a large footprint, and are not